CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-17 | DORSA CAROLINE Director | Grant or award | +3,160 | 31,002 | ||
| 2025-05-02 | DORSA CAROLINE Director | Purchase | +1,235 | $122.72 | $152K | 27,842 |
| 2024-06-21 | DORSA CAROLINE Director | Grant or award | +1,785 | 26,607 | ||
| 2023-06-26 | DORSA CAROLINE Director | Grant or award | +1,580 | 24,822 | ||
| 2022-06-15 | DORSA CAROLINE Director | Grant or award | +1,370 | 23,242 | ||
| 2021-07-01 | DORSA CAROLINE Director | Grant or award | +775 | 21,872 | ||
| 2020-06-03 | DORSA CAROLINE Director | Grant or award | +890 | 21,097 | ||
| 2019-06-19 | DORSA CAROLINE Director | Grant or award | +1,155 | 20,207 | ||
| 2018-06-12 | DORSA CAROLINE Director | Grant or award | +880 | 19,052 |
Page 1 of 1 · 9 trades